Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT

Arcturus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.18M -14.08M -30M -6.9M -17.22M -26.82M -8.57M -16.22M -52.55M 50.75M 117.35M -35.27M -21.56M -51.17M -38.66M -54.08M -54.58M -56.35M
Depreciation & Amortization
779K 801K 819K 912K 909K 904K 815K 827K 737K 578K 551K 417K 335K 224K 310K 289K 287K 307K
Stock-Based Compensation
6.2M 6.66M 8.98M 9.49M 9.42M 10.09M 8.81M 9.27M 8.38M 8.18M 6.53M 9.44M 7.27M 7.37M 7.52M 6.87M 7.54M 6.99M
Other Working Capital
n/a -16.93M -3.2M 23.07M -31.13M 1.34M 3.38M 8.99M 14.63M 15.84M 43.37M -26.88M -27.76M -6.24M -2.7M 38.19M -1.33M -1.37M
Other Non-Cash Items
-3.55M 21K -172K -40.59M 277.92K 53K 5.57M -70K -73.3M -33.29M 1.63M -78K 1.49M 1.15M 905K 894K 887K 5.7M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -16.7M n/a 73.3M n/a n/a n/a n/a n/a 501K -256K 351K -1.69M
Change in Working Capital
n/a -28.55M 20.09M 13.32M -23.54M 10.21M 9.54M -26.21M 94.24M -62.09M 34.21M -16.91M -23.24M -6.61M -13.07M 29.63M 12.57M 2.09M
Operating Cash Flow
-5.75M -35.14M -284K -23.76M -30.14M -5.56M -544.67K -32.41M 50.81M -35.87M 160.26M -42.41M -36.82M -49.04M -42.5M -16.65M -32.94M -42.95M
Capital Expenditures
n/a n/a -2.45K 563.35K -323.35K -240K -837.08K -981K -354K -691K -3.81M -2.19M 378K -2.11M -1.12M -1.77M -404K -118K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -643.35K -4.66K n/a n/a n/a n/a n/a -8.3M n/a n/a -2.11M -3.46M n/a n/a -118K
Investing Cash Flow
n/a -137K -2.45K -80K -328K -240K -837.08K -981K -354K -691K -3.81M -2.19M 378K -2.11M -1.12M -1.77M -404K -118K
Debt Repayment
n/a 15M n/a n/a n/a n/a -20M 20M n/a -27.36M -3M -2M n/a n/a n/a n/a n/a 46.6M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-14.73M n/a -19.95K -17.11K 37.62K n/a 728.03K 59.46K 94K n/a 37.92K 780K 257K 336K 230K 177K 82K 413K
Financial Cash Flow
-14.73M 15.2M 134K 693K 2.4M 2.19M -17.98M 21.84M 94K -27.36M -2.23M -1.22M 257K 336K 230K 692K 82K 47.01M
Net Cash Flow
-20.48M -20.08M -150K -23.15M -28.07M -3.61M 87K -11.55M 50.55M -63.93M 154.22M -45.81M -36.19M -50.81M -43.38M -17.73M -33.27M 3.94M
Free Cash Flow
-5.75M -35.14M -284K -23.49M -30.17M -5.8M -1.38M -33.39M 50.45M -36.56M 156.45M -44.59M -36.44M -51.15M -43.62M -18.42M -33.35M -43.07M